$98.82
+0.40 (+0.41%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
-79.1% upside
Low Target
$16.39
Average Target
$20.70
High Target
$27.30
Current Price
$98.82
Current
$98.82
$98.82
Target
$20.70
$20.70
$16.39
$20.70 avg
$27.30
Scenario Analysis
Bear Case
$16.39
-83.4%
Low target
Base Case
$20.70
-79.1%
Avg target
Bull Case
$27.30
+-72.4%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$99.80
-1.0% from high
52-Week Low
$12.84
+669.6% from low
Target vs 52W High
$20.70
-79.3% vs high
Next Earnings Report
Aug 17, 2026
6d
until earnings
EPS Est: $-0.53
Earnings in 6 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |